Search Within

Radiation Oncology, Department of

Formats
  1. Journal Article (2433)
  2. Meeting Abstract (2044)
  3. Book Section (299)
  4. Review (186)
  5. Editorial (106)
  6. Correspondence (73)
  7. Guidelines (63)
  8. Research Letter (34)
  9. Conference Paper (31)
  10. Book Whole (8)
  11. Miscellaneous (7)
Groups
  1. Survivorship Research (2238)
  2. Department of Medicine (1589)
  3. Surgery (1350)
  4. Solid Tumor Oncology Division (1188)
  5. Medical Physics (940)
  6. GSK Faculty (924)

More Groups

People
  1. Nancy Lee (896)
  2. Joachim Yahalom (635)
  3. Suzanne Wolden (566)
  4. Yoshiya Yamada (480)
  5. Nadeem Riaz (423)
  6. Abraham Wu (405)

More People

Years
  1. 2026 (1)
  2. 2025 (259)
  3. 2024 (411)
  4. 2023 (365)
  5. 2022 (371)
  6. 2021 (359)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (1494)
  2. Journal of Clinical Oncology (404)
  3. Medical Physics (135)
  4. Radiotherapy and Oncology (128)
  5. Blood (118)
  6. Gynecologic Oncology (110)

More Publications

Publishers
  1. Elsevier Inc. (2047)
  2. American Society of Clinical Oncology (434)
  3. Springer (217)
  4. Wiley Blackwell (194)
  5. Lippincott Williams & Wilkins (188)
  6. Oxford University Press (182)

More Publishers

Results (5284)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and extramedullary plasmacytomas
    Meeting Abstract

    Fregonese, B.; Dreyfuss, A.; Lee, J.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Blood (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of splenic irradiation for non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Imber, B. S.; Wijetunga, N. A.; Tringale, K. R.; Hajj, C.; Yahalom, J.
    Blood (2022)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes
    Meeting Abstract

    Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
    Blood (2022)

    Fulltext@MSK | Save
  • Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: Characterization of a large cohort with long-term outcomes shows disparate outcomes by body region involvement
    Meeting Abstract

    Stuver, R.; Ghione, P.; Ganesan, N.; Noor, S.; Imber, B. S.; Pulitzer, M.; Horwitz, S. M.
    Blood (2022)

    Fulltext@MSK | Save
  • Genetic Alterations of CREBBP are associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Lee, J.; Fregonese, B.; Tringale, K. R.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • "Big Boom" (4 Gy x 1) radiation treatment (RT) versus "Big Boom" (2 Gy x 2) for non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Hajj, C.; Lebow, E. S.; Lee, J.; Fregonese, B.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K. R.; Freret, M. E.; Imber, B. S.; Yahalom, J.
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Initial treatment response is prognostic and predictive of relapse patterns: Outcomes of >500 patients treated for primary CNS lymphoma
    Meeting Abstract

    Tringale, K. R.; Yahalom, J.; Scordo, M.; Cederquist, G. Y.; Vachha, B.; Schaff, L.; Hajj, C.; Hubbeling, H.; Zhang, Z.; White, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
    Journal Article

    Chatila, W. K.; Kim, J. K.; Walch, H.; Marco, M. R.; Chen, C. T.; Wu, F.; Omer, D. M.; Khalil, D. N.; Ganesh, K.; Qu, X.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save